BioSpace News Archive

HealthTree®, the first online portal for multiple myeloma cancer patients to find their best treatment options and help accelerate a cure, today announced that in less than a month, 1,066 patients have joined an observational study on Covid-19 and multiple myeloma.

CellResearch Corporation (CellResearch), a regenerative medicine biotechnology company , is making its cGMP-grade umbilical cord lining stem cell product, CorLiCyte® , available complimentary to any licensed medical institution that is seeking to initiate clinical trials for the treatment of COVID-19 related therapies such as Ac

Vivera Pharmaceuticals, Inc., a California -based pharmaceutical company focused on putting patients first, announces the launch of their point-of-care ready rapid serology tests. Bringing man

Wolters Kluwer, Health , a leading global provider of information and point of care solutions for the healthcare industry, has joined forces with the American Diabetes Association (ADA) and other collaborators to develop and virtually host its 80th Scientific Sessions: A Virtual Experience from June 12 through 16. The ADA’s annual, in-person meeting has been transformed into a fully digital experience leveraging com

Dimer LLC announces that it has entered into an exclusive, worldwide strategic partnership with Honeywell International Inc. to bring germicidal UV lighting technology to the Aerospace industry.

Tychan, a Singapore-based clinical-stage biotechnology company, is initiating Phase 1 clinical trials to evaluate TY027, the first novel monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19.

The Muscular Dystrophy Association invites you to join a special virtual conversation on Facebook Live featuring MDA Medical Consultant Dr. John W. Day and MDA Director of Care Center Programs, Marydeth Guerin

A new survey by the International Atherosclerosis Society (IAS) provided a ‘snapshot’ of the gaps in knowledge among clinicians that limit best practice.

Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing.

Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, CEO, will present at the Goldman Sachs 41st Annual Global Healthcare Conference at 8:00 AM EDT on June 11. A live audio webcast of Mr. Raythatha’s presenta